Multiple myeloma expert Dr. James Berenson, from the Institute for Myeloma and Bone Cancer Research, discusses research on repurposing certain drugs that have been effective for other cancers to treat myeloma, and re-combining myeloma treatments to reduce toxicities. Watch as Dr. Berenson shares findings on therapies originally approved for myeloproliferative neoplasms (MPNs) and chronic lymphocytic leukemia (CLL) showing benefit for myeloma patients.